Dar Al Dawa Development and Investment Co. Ltd. (ASE:DADI)

Market Cap	41.30M
Revenue (ttm)	82.70M
Net Income (ttm)	4.14M
Shares Out	35.00M
EPS (ttm)	0.12
PE Ratio	9.94
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,163
Average Volume	26,948
Open	1.190
Previous Close	1.190
Day's Range	1.180 - 1.190
52-Week Range	1.100 - 1.310
Beta	0.24
RSI	51.41
Earnings Date	Jul 31, 2025

About ASE:DADI

Dar Al Dawa Development and Investment Co. Ltd., an integrated pharmaceutical company, develops, manufactures, markets, and distributes pharmaceutical and consumer healthcare products in Levant, Gulf and Yemen, the Middle East, Africa, Europe, and Asia. It operates through Medicine; and Infants’ Cereals and Milk Formula segments. The company offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, urology, respiratory, gastrointestinal, analgesic and musculoskeletal, central nervous system, gynecology, dermatolog...

• Industry: Pharmaceutical Preparations
• Founded: 1975
• Employees: 1,111
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: DADI

Financial Performance

In 2024, ASE:DADI's revenue was 81.18 million, an increase of 8.42% compared to the previous year's 74.88 million. Earnings were 3.59 million, an increase of 13.41%.